 | • レポートコード：QYR9ST03936 • 出版社/出版日：QYResearch / 2019年9月2日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、96ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医療・製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| ※当調査レポートでは、腎線維症治療の世界市場について調査・分析し、腎線維症治療の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（アンジオテンシン変換酵素（ACE）阻害剤、ピルフェニドン、レニン阻害剤、アンジオテンシンII受容体遮断薬（ARB）、バソペプチダーゼ阻害剤）、用途別（慢性腎臓病、腎臓癌治療、その他）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界の腎線維症治療市場動向 ・主要企業別マーケットシェア ・腎線維症治療の種類別市場規模2014-2019 （アンジオテンシン変換酵素（ACE）阻害剤、ピルフェニドン、レニン阻害剤、アンジオテンシンII受容体遮断薬（ARB）、バソペプチダーゼ阻害剤） ・腎線維症治療の用途別市場規模2014-2019 （慢性腎臓病、腎臓癌治療、その他） ・腎線維症治療の北米市場：主要企業・種類別/用途別市場規模 ・腎線維症治療のヨーロッパ市場：主要企業・種類別/用途別市場規模 ・腎線維症治療の中国市場：主要企業・種類別/用途別市場規模 ・腎線維症治療の日本国内市場：主要企業・種類別/用途別市場規模 ・腎線維症治療の東南アジア市場：主要企業・種類別/用途別市場規模 ・腎線維症治療のインド市場：主要企業・種類別/用途別市場規模 ・腎線維症治療の中南米市場：主要企業・種類別/用途別市場規模 ・主要企業のプロフィール （Merck & Co(US)、Pfizer Inc(US)、F. Hoffman-La Roche(Switzerland)、InterMune Inc(US)、Galectin Therapeutics(US)、La Jolla Pharmaceutical Company(US)、ProMetic Life-Sciences Inc(Canada)、BioLine Rx(Israel)、Genzyme Corporation(US)） ・腎線維症治療の市場規模予測2019-2025 （種類別、用途別、地域別市場予測） ・アナリストの観点・結論 ... |
Kidney or renal fibrosis is the body process from which the kidney’s excess fibrous connective tissue or organs takes its formation repetitively.Increasing prevalence of chronic diseases such as kidney disorders is expected to trigger the growth of this market over the forecast period. Changing life style coupled with changing food habits is the prime reason for rising base of kidney disease patients and is expected to boost the market for kidney fibrosis treatments. Furthermore, factors such as increasing global geriatric population base, rising disposable income of the patients and growing awareness about renal fibrosis treatment are vital factor for growth of this market during the forecast period. Continuous innovation in technology has led to development of safe and effective therapies for the treatment of chronic kidney diseases is also pushing the growth of kidney fibrosis treatment market.
In 2018, the global Kidney Fibrosis Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Kidney Fibrosis Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Kidney Fibrosis Treatment development in United States, Europe and China.
The key players covered in this study
Merck & Co(US)
Pfizer Inc(US)
F. Hoffman-La Roche(Switzerland)
InterMune Inc(US)
Galectin Therapeutics(US)
La Jolla Pharmaceutical Company(US)
ProMetic Life-Sciences Inc(Canada)
BioLine Rx(Israel)
Genzyme Corporation(US)
Market segment by Type, the product can be split into
Angiotensin Converting Enzyme (ACE) Inhibitors
Pirfenidone
Renin Inhibitors
Angiotensin II Receptor Blockers (ARBs)
Vasopeptidase Inhibitors
Market segment by Application, split into
Chronic Kidney Diseases
Kidney Cancer Treatment
Others
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Kidney Fibrosis Treatment status, future forecast, growth opportunity, key market and key players.
To present the Kidney Fibrosis Treatment development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Kidney Fibrosis Treatment are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Kidney Fibrosis Treatment Market Size Growth Rate by Type (2014-2025)
1.4.2 Angiotensin Converting Enzyme (ACE) Inhibitors
1.4.3 Pirfenidone
1.4.4 Renin Inhibitors
1.4.5 Angiotensin II Receptor Blockers (ARBs)
1.4.6 Vasopeptidase Inhibitors
1.5 Market by Application
1.5.1 Global Kidney Fibrosis Treatment Market Share by Application (2014-2025)
1.5.2 Chronic Kidney Diseases
1.5.3 Kidney Cancer Treatment
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Kidney Fibrosis Treatment Market Size
2.2 Kidney Fibrosis Treatment Growth Trends by Regions
2.2.1 Kidney Fibrosis Treatment Market Size by Regions (2014-2025)
2.2.2 Kidney Fibrosis Treatment Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Kidney Fibrosis Treatment Market Size by Manufacturers
3.1.1 Global Kidney Fibrosis Treatment Revenue by Manufacturers (2014-2019)
3.1.2 Global Kidney Fibrosis Treatment Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Kidney Fibrosis Treatment Market Concentration Ratio (CR5 and HHI)
3.2 Kidney Fibrosis Treatment Key Players Head office and Area Served
3.3 Key Players Kidney Fibrosis Treatment Product/Solution/Service
3.4 Date of Enter into Kidney Fibrosis Treatment Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Kidney Fibrosis Treatment Market Size by Type (2014-2019)
4.2 Global Kidney Fibrosis Treatment Market Size by Application (2014-2019)
5 United States
5.1 United States Kidney Fibrosis Treatment Market Size (2014-2019)
5.2 Kidney Fibrosis Treatment Key Players in United States
5.3 United States Kidney Fibrosis Treatment Market Size by Type
5.4 United States Kidney Fibrosis Treatment Market Size by Application
6 Europe
6.1 Europe Kidney Fibrosis Treatment Market Size (2014-2019)
6.2 Kidney Fibrosis Treatment Key Players in Europe
6.3 Europe Kidney Fibrosis Treatment Market Size by Type
6.4 Europe Kidney Fibrosis Treatment Market Size by Application
7 China
7.1 China Kidney Fibrosis Treatment Market Size (2014-2019)
7.2 Kidney Fibrosis Treatment Key Players in China
7.3 China Kidney Fibrosis Treatment Market Size by Type
7.4 China Kidney Fibrosis Treatment Market Size by Application
8 Japan
8.1 Japan Kidney Fibrosis Treatment Market Size (2014-2019)
8.2 Kidney Fibrosis Treatment Key Players in Japan
8.3 Japan Kidney Fibrosis Treatment Market Size by Type
8.4 Japan Kidney Fibrosis Treatment Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Kidney Fibrosis Treatment Market Size (2014-2019)
9.2 Kidney Fibrosis Treatment Key Players in Southeast Asia
9.3 Southeast Asia Kidney Fibrosis Treatment Market Size by Type
9.4 Southeast Asia Kidney Fibrosis Treatment Market Size by Application
10 India
10.1 India Kidney Fibrosis Treatment Market Size (2014-2019)
10.2 Kidney Fibrosis Treatment Key Players in India
10.3 India Kidney Fibrosis Treatment Market Size by Type
10.4 India Kidney Fibrosis Treatment Market Size by Application
11 Central & South America
11.1 Central & South America Kidney Fibrosis Treatment Market Size (2014-2019)
11.2 Kidney Fibrosis Treatment Key Players in Central & South America
11.3 Central & South America Kidney Fibrosis Treatment Market Size by Type
11.4 Central & South America Kidney Fibrosis Treatment Market Size by Application
12 International Players Profiles
12.1 Merck & Co(US)
12.1.1 Merck & Co(US) Company Details
12.1.2 Company Description and Business Overview
12.1.3 Kidney Fibrosis Treatment Introduction
12.1.4 Merck & Co(US) Revenue in Kidney Fibrosis Treatment Business (2014-2019)
12.1.5 Merck & Co(US) Recent Development
12.2 Pfizer Inc(US)
12.2.1 Pfizer Inc(US) Company Details
12.2.2 Company Description and Business Overview
12.2.3 Kidney Fibrosis Treatment Introduction
12.2.4 Pfizer Inc(US) Revenue in Kidney Fibrosis Treatment Business (2014-2019)
12.2.5 Pfizer Inc(US) Recent Development
12.3 F. Hoffman-La Roche(Switzerland)
12.3.1 F. Hoffman-La Roche(Switzerland) Company Details
12.3.2 Company Description and Business Overview
12.3.3 Kidney Fibrosis Treatment Introduction
12.3.4 F. Hoffman-La Roche(Switzerland) Revenue in Kidney Fibrosis Treatment Business (2014-2019)
12.3.5 F. Hoffman-La Roche(Switzerland) Recent Development
12.4 InterMune Inc(US)
12.4.1 InterMune Inc(US) Company Details
12.4.2 Company Description and Business Overview
12.4.3 Kidney Fibrosis Treatment Introduction
12.4.4 InterMune Inc(US) Revenue in Kidney Fibrosis Treatment Business (2014-2019)
12.4.5 InterMune Inc(US) Recent Development
12.5 Galectin Therapeutics(US)
12.5.1 Galectin Therapeutics(US) Company Details
12.5.2 Company Description and Business Overview
12.5.3 Kidney Fibrosis Treatment Introduction
12.5.4 Galectin Therapeutics(US) Revenue in Kidney Fibrosis Treatment Business (2014-2019)
12.5.5 Galectin Therapeutics(US) Recent Development
12.6 La Jolla Pharmaceutical Company(US)
12.6.1 La Jolla Pharmaceutical Company(US) Company Details
12.6.2 Company Description and Business Overview
12.6.3 Kidney Fibrosis Treatment Introduction
12.6.4 La Jolla Pharmaceutical Company(US) Revenue in Kidney Fibrosis Treatment Business (2014-2019)
12.6.5 La Jolla Pharmaceutical Company(US) Recent Development
12.7 ProMetic Life-Sciences Inc(Canada)
12.7.1 ProMetic Life-Sciences Inc(Canada) Company Details
12.7.2 Company Description and Business Overview
12.7.3 Kidney Fibrosis Treatment Introduction
12.7.4 ProMetic Life-Sciences Inc(Canada) Revenue in Kidney Fibrosis Treatment Business (2014-2019)
12.7.5 ProMetic Life-Sciences Inc(Canada) Recent Development
12.8 BioLine Rx(Israel)
12.8.1 BioLine Rx(Israel) Company Details
12.8.2 Company Description and Business Overview
12.8.3 Kidney Fibrosis Treatment Introduction
12.8.4 BioLine Rx(Israel) Revenue in Kidney Fibrosis Treatment Business (2014-2019)
12.8.5 BioLine Rx(Israel) Recent Development
12.9 Genzyme Corporation(US)
12.9.1 Genzyme Corporation(US) Company Details
12.9.2 Company Description and Business Overview
12.9.3 Kidney Fibrosis Treatment Introduction
12.9.4 Genzyme Corporation(US) Revenue in Kidney Fibrosis Treatment Business (2014-2019)
12.9.5 Genzyme Corporation(US) Recent Development
13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
Table Kidney Fibrosis Treatment Key Market Segments
Table Key Players Kidney Fibrosis Treatment Covered
Table Global Kidney Fibrosis Treatment Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Kidney Fibrosis Treatment Market Size Market Share by Type 2014-2025
Figure Angiotensin Converting Enzyme (ACE) Inhibitors Figures
Table Key Players of Angiotensin Converting Enzyme (ACE) Inhibitors
Figure Pirfenidone Figures
Table Key Players of Pirfenidone
Figure Renin Inhibitors Figures
Table Key Players of Renin Inhibitors
Figure Angiotensin II Receptor Blockers (ARBs) Figures
Table Key Players of Angiotensin II Receptor Blockers (ARBs)
Figure Vasopeptidase Inhibitors Figures
Table Key Players of Vasopeptidase Inhibitors
Table Global Kidney Fibrosis Treatment Market Size Growth by Application 2014-2025 (Million US$)
Figure Chronic Kidney Diseases Case Studies
Figure Kidney Cancer Treatment Case Studies
Figure Others Case Studies
Figure Kidney Fibrosis Treatment Report Years Considered
Table Global Kidney Fibrosis Treatment Market Size 2014-2025 (Million US$)
Figure Global Kidney Fibrosis Treatment Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Kidney Fibrosis Treatment Market Size by Regions 2014-2025 (Million US$)
Table Global Kidney Fibrosis Treatment Market Size by Regions 2014-2019 (Million US$)
Table Global Kidney Fibrosis Treatment Market Share by Regions 2014-2019
Figure Global Kidney Fibrosis Treatment Market Share by Regions 2014-2019
Figure Global Kidney Fibrosis Treatment Market Share by Regions 2019
Table Market Top Trends
Table Global Kidney Fibrosis Treatment Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Kidney Fibrosis Treatment Market Share by Manufacturers (2014-2019)
Figure Global Kidney Fibrosis Treatment Market Share by Manufacturers in 2018
Table Global Kidney Fibrosis Treatment Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Kidney Fibrosis Treatment Product/Solution/Service
Table Date of Enter into Kidney Fibrosis Treatment Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Kidney Fibrosis Treatment Market Size by Type (2014-2019) (Million US$)
Table Global Kidney Fibrosis Treatment Market Size Share by Type (2014-2019)
Figure Global Kidney Fibrosis Treatment Market Size Market Share by Type (2014-2019)
Table Global Kidney Fibrosis Treatment Market Size by Application (2014-2019) (Million US$)
Table Global Kidney Fibrosis Treatment Market Size Share by Application (2014-2019)
Figure Global Kidney Fibrosis Treatment Market Size Market Share by Application (2014-2019)
Figure Global Kidney Fibrosis Treatment Revenue Market Share by Application in 2018
Figure United States Kidney Fibrosis Treatment Market Size 2014-2019 (Million US$)
Table United States Key Players Kidney Fibrosis Treatment Revenue (2018-2019) (Million US$)
Table United States Key Players Kidney Fibrosis Treatment Market Share (2018-2019)
Table United States Kidney Fibrosis Treatment Market Size by Type (2014-2019) (Million US$)
Table United States Kidney Fibrosis Treatment Market Share by Type (2014-2019)
Table United States Kidney Fibrosis Treatment Market Size by Application (2014-2019) (Million US$)
Table United States Kidney Fibrosis Treatment Market Share by Application (2014-2019)
Figure Europe Kidney Fibrosis Treatment Market Size 2014-2019 (Million US$)
Table Europe Key Players Kidney Fibrosis Treatment Revenue (2018-2019) (Million US$)
Table Europe Key Players Kidney Fibrosis Treatment Market Share (2018-2019)
Table Europe Kidney Fibrosis Treatment Market Size by Type (2014-2019) (Million US$)
Table Europe Kidney Fibrosis Treatment Market Share by Type (2014-2019)
Table Europe Kidney Fibrosis Treatment Market Size by Application (2014-2019) (Million US$)
Table Europe Kidney Fibrosis Treatment Market Share by Application (2014-2019)
Figure China Kidney Fibrosis Treatment Market Size 2014-2019 (Million US$)
Table China Key Players Kidney Fibrosis Treatment Revenue (2018-2019) (Million US$)
Table China Key Players Kidney Fibrosis Treatment Market Share (2018-2019)
Table China Kidney Fibrosis Treatment Market Size by Type (2014-20189) (Million US$)
Table China Kidney Fibrosis Treatment Market Share by Type (2014-2019)
Table China Kidney Fibrosis Treatment Market Size by Application (2014-2019) (Million US$)
Table China Kidney Fibrosis Treatment Market Share by Application (2014-2019)
Figure Japan Kidney Fibrosis Treatment Market Size 2014-2019 (Million US$)
Table Japan Key Players Kidney Fibrosis Treatment Revenue (2018-2019) (Million US$)
Table Japan Key Players Kidney Fibrosis Treatment Market Share (2018-2019)
Table Japan Kidney Fibrosis Treatment Market Size by Type (2014-2019) (Million US$)
Table Japan Kidney Fibrosis Treatment Market Share by Type (2014-2019)
Table Japan Kidney Fibrosis Treatment Market Size by Application (2014-2019) (Million US$)
Table Japan Kidney Fibrosis Treatment Market Share by Application (2014-2019)
Figure Southeast Asia Kidney Fibrosis Treatment Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Kidney Fibrosis Treatment Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Kidney Fibrosis Treatment Market Share (2018-2019)
Table Southeast Asia Kidney Fibrosis Treatment Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Kidney Fibrosis Treatment Market Share by Type (2014-2019)
Table Southeast Asia Kidney Fibrosis Treatment Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Kidney Fibrosis Treatment Market Share by Application (2014-2019)
Figure India Kidney Fibrosis Treatment Market Size 2014-2019 (Million US$)
Table India Key Players Kidney Fibrosis Treatment Revenue (2018-2019) (Million US$)
Table India Key Players Kidney Fibrosis Treatment Market Share (2018-2019)
Table India Kidney Fibrosis Treatment Market Size by Type (2014-2019) (Million US$)
Table India Kidney Fibrosis Treatment Market Share by Type (2014-2019)
Table India Kidney Fibrosis Treatment Market Size by Application (2014-2019) (Million US$)
Table India Kidney Fibrosis Treatment Market Share by Application (2014-2019)
Figure Central & South America Kidney Fibrosis Treatment Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Kidney Fibrosis Treatment Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Kidney Fibrosis Treatment Market Share (2018-2019)
Table Central & South America Kidney Fibrosis Treatment Market Size by Type (2014-2019) (Million US$)
Table Central & South America Kidney Fibrosis Treatment Market Share by Type (2014-2019)
Table Central & South America Kidney Fibrosis Treatment Market Size by Application (2014-2019) (Million US$)
Table Central & South America Kidney Fibrosis Treatment Market Share by Application (2014-2019)
Table Merck & Co(US) Company Details
Table Merck & Co(US) Revenue in Kidney Fibrosis Treatment Business (2014-2019) (Million US$)
Figure Merck & Co(US) Revenue Growth Rate in Kidney Fibrosis Treatment Business (2014-2019)
Table Merck & Co(US) Recent Development
Table Pfizer Inc(US) Company Details
Table Pfizer Inc(US) Revenue in Kidney Fibrosis Treatment Business (2014-2019)(Million US$)
Figure Pfizer Inc(US) Revenue Growth Rate in Kidney Fibrosis Treatment Business (2014-2019)
Table Pfizer Inc(US) Recent Development
Table F. Hoffman-La Roche(Switzerland) Company Details
Table F. Hoffman-La Roche(Switzerland) Revenue in Kidney Fibrosis Treatment Business (2014-2019)(Million US$)
Figure F. Hoffman-La Roche(Switzerland) Revenue Growth Rate in Kidney Fibrosis Treatment Business (2014-2019)
Table F. Hoffman-La Roche(Switzerland) Recent Development
Table InterMune Inc(US) Company Details
Table InterMune Inc(US) Revenue in Kidney Fibrosis Treatment Business (2014-2019)(Million US$)
Figure InterMune Inc(US) Revenue Growth Rate in Kidney Fibrosis Treatment Business (2014-2019)
Table InterMune Inc(US) Recent Development
Table Galectin Therapeutics(US) Company Details
Table Galectin Therapeutics(US) Revenue in Kidney Fibrosis Treatment Business (2014-2019)(Million US$)
Figure Galectin Therapeutics(US) Revenue Growth Rate in Kidney Fibrosis Treatment Business (2014-2019)
Table Galectin Therapeutics(US) Recent Development
Table La Jolla Pharmaceutical Company(US) Company Details
Table La Jolla Pharmaceutical Company(US) Revenue in Kidney Fibrosis Treatment Business (2014-2019)(Million US$)
Figure La Jolla Pharmaceutical Company(US) Revenue Growth Rate in Kidney Fibrosis Treatment Business (2014-2019)
Table La Jolla Pharmaceutical Company(US) Recent Development
Table ProMetic Life-Sciences Inc(Canada) Company Details
Table ProMetic Life-Sciences Inc(Canada) Revenue in Kidney Fibrosis Treatment Business (2014-2019)(Million US$)
Figure ProMetic Life-Sciences Inc(Canada) Revenue Growth Rate in Kidney Fibrosis Treatment Business (2014-2019)
Table ProMetic Life-Sciences Inc(Canada) Recent Development
Table BioLine Rx(Israel) Company Details
Table BioLine Rx(Israel) Revenue in Kidney Fibrosis Treatment Business (2014-2019)(Million US$)
Figure BioLine Rx(Israel) Revenue Growth Rate in Kidney Fibrosis Treatment Business (2014-2019)
Table BioLine Rx(Israel) Recent Development
Table Genzyme Corporation(US) Company Details
Table Genzyme Corporation(US) Revenue in Kidney Fibrosis Treatment Business (2014-2019)(Million US$)
Figure Genzyme Corporation(US) Revenue Growth Rate in Kidney Fibrosis Treatment Business (2014-2019)
Table Genzyme Corporation(US) Recent Development
Table Global Kidney Fibrosis Treatment Market Size by Regions (Million US$) 2019-2025
Figure Global Kidney Fibrosis Treatment Market Size Share by Regions (2019-2025)
Figure Global Kidney Fibrosis Treatment Market Size Share by Regions in 2025
Figure United States Kidney Fibrosis Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Europe Kidney Fibrosis Treatment Market Size Forecast (2019-2025)(Million USD)
Figure China Kidney Fibrosis Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Japan Kidney Fibrosis Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Kidney Fibrosis Treatment Market Size Forecast (2019-2025)(Million USD)
Figure India Kidney Fibrosis Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Kidney Fibrosis Treatment Market Size Forecast (2019-2025)(Million USD)
Table Global Kidney Fibrosis Treatment Market Size by Product (2019-2025) (Million US$)
Figure Global Kidney Fibrosis Treatment Market Size by Product (2019-2025)
Figure Global Kidney Fibrosis Treatment Market Size by Product in 2025
Table Global Kidney Fibrosis Treatment Market Size by Application (2019-2025) (Million US$)
Figure Global Kidney Fibrosis Treatment Market Size by Application (2019-2025)
Figure Global Kidney Fibrosis Treatment Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
腎臓癌治療薬の世界市場：市場規模・現状・予測 Kidney Cancer Treatment Drugs are drugs used to cure kidney cancer.Market growth is largely driven by factors such as availability of novel drugs, presence of strong pipeline, and rise in incidence of renal cancer due to growing geriatric population and more prominent smoking habits. In 2018, the gl…- 皮膚線維症の治療の世界市場：市場規模・現状・予測 Cutaneous fibrosis is the accumulation of extracellular matrix (ECM) components in the dermis, leading to compromised function and altered architecture of the dermis. Development of fibrosis occurs naturally during scar formation in wound repair or is a pathological process in pro-fibrotic diseases.…
- 急性腎障害治療の世界市場：市場規模・現状・予測 Acute kidney injury (AKI) is where your kidneys suddenly stop working properly. It can range from minor loss of kidney function to complete kidney failure.In 2018, the global Acute Kidney Injury Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, w…
- 急性腎障害治療及び管理の世界市場：市場規模・現状・予測 KI happens in people who are already sick and in the hospital. People who are in the intensive care unit (ICU) are even more likely than people who are in other units of the hospital to have AKI. This is because people who need to be in the ICU are already very sick.In 2018, the global Acute Kidney …
- mTOR阻害剤の世界市場：インサイト・予測 mTOR inhibitors are a class of drugs that inhibit the mechanistic target of rapamycin (mTOR).Mammalian target of rapamycin (mTOR) inhibitors block the activity of the mammalian target of rapamycin. Mammalian target of rapamycin is a protein kinase, which regulates growth factors that stimulate cell …